🔍 Rechercher dans les archives
Wellgistics Health, Inc. (NASDAQ:WGRX) Sees Large Increase in Short Interest
Wellgistics Health, Inc. (NASDAQ:WGRX – Get Free Report) was the target of a large growth in short interest in February. As of February 27th, there ...
Keona Health: Fragmented Patient Access Systems Drive No-Shows and Missed Calls
Disconnected Scheduling Are Costing Healthcare Organizations Patients — Keona Health Shows How to Fix the Gaps Chapel...
Problematic social media use predicts higher depressive symptoms in adolescents under 16
Problematic use of social media—characterized by loss of control and compulsive engagement—may significantly increase depressive symptoms in adole...
Walk More to Stress Less: Get Moving to Improve Well-Being
...
Walk More to Stress Less: Get Moving to Improve Well-Being
...
Walk More to Stress Less: Get Moving to Improve Well-Being
...
Walk More to Stress Less: Get Moving to Improve Well-Being
...
Walk More to Stress Less: Get Moving to Improve Well-Being
...
Vitamin B2 Pathway Identified as Potential Target for Cancer Therapy
Vitamin B2 metabolism helps cancer cells resist ferroptosis, a form of programmed cell death. Targeting riboflavin-related pathways with compounds lik...
'Those of you who look like me': Director says Oscar opened doors for Koreans, despite previous wins
When "KPop Demon Hunters" won the Academy Award for best animated feature film, the director falsely claimed the film's victory was the first such ins...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispec...
From $500 to $1.5K: Marylanders feel financial impact of expired ACA tax credits
Michael Zabetakis’ monthly health insurance premium nearly tripled when the enhanced Affordable Care Act tax credits expired in January — rising f...
Family Medicine Services Market 2026 Rising Demand For Primary Care Supporting Industry Growth
(MENAFN - EIN Presswire) EINPresswire/ -- Family Medicine Services market to surpass $625 billion in 2030. Within the broader Healthcare Services indu...